Zhao M - Search Results

1

Engineering CAR-NK cells targeting CD33 with concomitant extracellular secretion of anti-CD16 antibody revealed superior antitumor effects toward myeloid leukemia.

Zhang R, Liu Q, Zhou S, He H, Zhao M, Ma W. Zhang R, et al. Among authors: zhao m. Cancer Lett. 2023 Apr 1;558:216103. doi: 10.1016/j.canlet.2023.216103. Epub 2023 Feb 17. Cancer Lett. 2023. PMID: 36805460

2

Effect and changes in PD‑1 expression of CD19 CAR‑T cells from T cells highly expressing PD‑1 combined with reduced‑dose PD‑1 inhibitor.

Zhang R, Deng Q, Jiang YY, Zhu HB, Wang J, Zhao MF. Zhang R, et al. Oncol Rep. 2019 Jun;41(6):3455-3463. doi: 10.3892/or.2019.7096. Epub 2019 Apr 3. Oncol Rep. 2019. PMID: 30942469

3

Gene knockout in cellular immunotherapy: Application and limitations.

Zhang X, Jin X, Sun R, Zhang M, Lu W, Zhao M. Zhang X, et al. Among authors: zhao m. Cancer Lett. 2022 Aug 1;540:215736. doi: 10.1016/j.canlet.2022.215736. Epub 2022 May 13. Cancer Lett. 2022. PMID: 35569695 Free article. Review.

4

Mesenchymal stem cell suppresses the efficacy of CAR-T toward killing lymphoma cells by modulating the microenvironment through stanniocalcin-1.

Zhang R, Liu Q, Zhou S, He H, Zhao M, Ma W. Zhang R, et al. Among authors: zhao m. Elife. 2023 Feb 13;12:e82934. doi: 10.7554/eLife.82934. Elife. 2023. PMID: 36779699 Free PMC article.

5

Targeted CD7 CAR T-cells for treatment of T-Lymphocyte leukemia and lymphoma and acute myeloid leukemia: recent advances.

Liu J, Zhang Y, Guo R, Zhao Y, Sun R, Guo S, Lu W, Zhao M. Liu J, et al. Among authors: zhao y, zhao m. Front Immunol. 2023 May 5;14:1170968. doi: 10.3389/fimmu.2023.1170968. eCollection 2023. Front Immunol. 2023. PMID: 37215124 Free PMC article. Review.

6

A CAR-T response prediction model for r/r B-NHL patients based on a T cell subset nomogram.

Zhang X, Sun R, Zhang M, Zhao Y, Cao X, Guo R, Zhang Y, Liu X, Lyu C, Zhao M. Zhang X, et al. Among authors: zhao y, zhao m. Cancer Immunol Immunother. 2024 Jan 27;73(2):33. doi: 10.1007/s00262-023-03618-w. Cancer Immunol Immunother. 2024. PMID: 38280081 Free PMC article.

7

Case report: Successful combination of CLL1 CAR-T therapy and hematopoietic stem cell transplantation in a 73-year-old patient diagnosed with refractory acute myeloid leukemia.

Zhao Y, Wang H, Zhang Y, Zhang Y, Zhang X, Zhao M, Liu J, Guo S, Zhao M. Zhao Y, et al. Among authors: zhao m. Front Immunol. 2024 Sep 17;15:1454614. doi: 10.3389/fimmu.2024.1454614. eCollection 2024. Front Immunol. 2024. PMID: 39355240 Free PMC article.

8

Efficacy and safety of CAR-T therapy targeting CLL1 in patients with extramedullary diseases of acute myeloid leukemia.

Zhao Y, Bai X, Guo S, Zhang X, Liu J, Zhao M, Xie T, Meng H, Zhang Y, He X, Zhao M. Zhao Y, et al. Among authors: zhao m. J Transl Med. 2024 Oct 2;22(1):888. doi: 10.1186/s12967-024-05705-7. J Transl Med. 2024. PMID: 39358720 Free PMC article.

9

Modified CD15/CD16-CLL1 inhibitory CAR-T cells for mitigating granulocytopenia toxicities in the treatment of acute myeloid leukemia.

Zhang R, Zhao Y, Chai X, Wang Y, Zhao M, Guo S, Zhang Y, Zhao M. Zhang R, et al. Among authors: zhao y, zhao m. Transl Oncol. 2024 Dec 7;52:102225. doi: 10.1016/j.tranon.2024.102225. Online ahead of print. Transl Oncol. 2024. PMID: 39647325 Free PMC article.

10

Effect of CIK on multidrug-resistance reversal and increasing the sensitivity of ADR in K562/ADR cells.

Wang L, Deng Q, Wang J, Bai X, Xiao X, Lv HR, Zhao MF, Liu PJ. Wang L, et al. Oncol Lett. 2014 Oct;8(4):1778-1782. doi: 10.3892/ol.2014.2337. Epub 2014 Jul 10. Oncol Lett. 2014. PMID: 25202409 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,641 results

Search Page

Filters